Corrigendum to “A six-weekly (Q6W) dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation” [Eur J Canc 131 (2020) 68–75]
Titel:
Corrigendum to “A six-weekly (Q6W) dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation” [Eur J Canc 131 (2020) 68–75]
Auteur:
Lala, Mallika Li, Tommy Ruosi de Alwis, Dinesh P. Sinha, Vikram Mayawala, Kapil Li, Mengyao Yamamoto, Noboru Siu, Lillian L. Chartash, Elliot Aboshady, Hesham Jain, Lokesh